NASDAQ Composite opens in less than two hours and ImmunoGen‘s pre-market value is already 5.3% up.
The last session, NASDAQ Composite finished with ImmunoGen (IMGN) jumping 1.91% to $6.41. NASDAQ Composite jumped 0.78% to $14,020.33, following the last session’s upward trend on what was a somewhat positive trend exchanging session.
Today’s last reported volume for ImmunoGen is 1356357 which is 33.27% below its average volume of 2032673.
ImmunoGen’s last close was $6.29, 42.19% under its 52-week high of $10.88.
ImmunoGen’s sales growth is 29.7% for the present quarter and 24.6% for the next. The company’s growth estimates for the current quarter and the next is a negative 28.6% and a negative 53.8%, respectively.
Year-on-year quarterly revenue growth grew by 91.2%, now sitting on 132.3M for the twelve trailing months.
ImmunoGen’s Stock Yearly Top and Bottom Value
ImmunoGen’s stock is valued at $6.41 at 08:11 EST, way under its 52-week high of $10.88 and way above its 52-week low of $3.38.
ImmunoGen’s Moving Average
ImmunoGen’s value is below its 50-day moving average of $6.87 and way under its 200-day moving average of $7.44.
ImmunoGen’s last day, last week, and last month’s current volatility was 0.32%, 2.07%, and 2.36%, respectively.
ImmunoGen’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.37% (day), 5.54% (last week), and 5.43% (last month), respectively.
More news about ImmunoGen (IMGN).